Targeted Sequencing Yields High Rate of Pathogenic Variants in Both Single and Multilineage Pediatric Immune Cytopenias.
Genetically defined IEI was identified in 7.7% of children with immune cytopenias who underwent genetic testing. The high rate of genetic diagnoses in patients with both single- and multi-lineage immune cytopenias who were tested supports the clinical utility of genetic testing in these patients.